Recombinant Human CD43 Protein，His

CD43, also known as leukosialin or sialophorin, is a cell surface glycoprotein predominantly expressed on leukocytes and plays a critical role in cell adhesion, signaling, and immune response modulation. The investigation of CD43 recombinant proteins has gained momentum due to its potential implications in various immunological disorders, cancer, and infectious diseases. Structurally, CD43 is characterized by its extensive extracellular domain, which is heavily glycosylated, imparting a complex and dynamic nature that impacts its function. Research efforts have focused on generating recombinant CD43 proteins to elucidate its biological roles and interactions with other immune cell receptors. Such recombinant proteins facilitate the exploration of CD43's involvement in cell-mediated immunity, lymphocyte activation, and the modulation of inflammatory responses. Moreover, understanding the structure-function relationship of CD43 through recombinant studies can aid in designing therapeutic strategies aimed at manipulating immune pathways for clinical benefit. The development of CD43-based biologics and therapeutic antibodies also presents novel avenues for targeting immune evasion mechanisms in tumors. Overall, the study of CD43 recombinant proteins represents a promising frontier in immunology and therapeutic development, highlighting the importance of this glycoprotein in human health and disease.